This is the authors' abstract. We don't add key points for this paper.
Management of hepatic adenoma (HA) and focal nodular hyperplasia (FNH) heavily relies on the distinction between the 2 entities. Most FNH are not resected, whereas HA can be complicated by hemorrhage and malignancy and is generally excised. FNH is composed of benign hepatocytes and contains bile ductules. Historically, there are 2 main subtypes of FNH, classic/solid and telangiectatic (TFNH). Traditional descriptions of HA indicate that it does not contain ducts or ductules. Radiologic and pathologic features of TFNH pose difficulty in the classification of TFNH within the spectrum of benign hepatocellular lesions. TFNH has pathologic features that overlap with HA. Its radiologic features are atypical for classic FNH. Recent evidence from clonality studies, genomics, and proteomics shows the profile of TFNH as being more like that of HA. This review discusses the evolution of our understanding of TFNH, and its recent reclassification as an HA variant. There are conflicting results regarding the clonality of FNH between studies. Using X chromosome inactivation, a majority of TFNH lesions were found to be monoclonal in some series. Gene expression profiling showed the pattern of dysregulation of angiopoietin genes, angiopoietin-1 and -2, in TFNH to be closer to HA, and unlike that of classic FNH. Proteomic profiling of TFNH is closer to HA than classic FNH. It is important for the practicing pathologist to recognize the features of so-called TFNH and its reclassification as an adenoma variant because of management implications. This requires a paradigm shift in that the presence of ductules does not preclude the diagnosis of HA.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Maha Guindi (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: